No physician may be subject to disciplinary action by the North Dakota board of medicine for prescribing or administering amygdalin to a patient under the physician's care who has requested the substance unless the board, in a hearing conducted pursuant to chapter 28-32, has made a formal finding that the substance is harmful.
N.D. Cent. Code § 23-23.1-02
Disciplinary action for administering or prescribing laetrile subject to finding of harmfulness
Official source: North Dakota Legislative Branch. Reproduced from public-domain North Dakota statutes; confirm against the official source for the current text. Not legal advice.